Get the app
Teppo Huttunen
Statistician from Finland, founder of Eskimage, a company specializing in biostatistics and data science for biotech and pharma companies. Expert in dose selection for immuno-oncology drugs.
Best podcasts with Teppo Huttunen
Ranked by the Snipd community
Dec 16, 2024
• 22min
Early Development and The Dose Selection in the Immune-oncology
chevron_right
Teppo Huttunen, a Finnish statistician and founder of Eskimage, delves into the complexities of dose selection in immune-oncology. He discusses the challenges of traditional 3+3 design and advocates for the more flexible BOIN design. Teppo emphasizes the balance between safety and efficacy, exploring the crucial role statisticians play in oncology research. He also highlights the importance of industry trends, FDA guidance, and practical challenges in optimizing dose design, making this conversation essential for anyone interested in advancing oncology treatment.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app
